ERCC5 and breast cancer: Of interest, low expression levels of the PDE9A, ERCC5, Iqca, Sirpb1b, CD244, SP140, and PIP5k1b genes were associated with decreased 5-year survival rate in BC patients, thus suggesting their potential association with unfavorable prognosis (Figure S11B).